• Home
  • Browse
    • Current Issue
    • By Issue
    • By Author
    • By Subject
    • Author Index
    • Keyword Index
  • Journal Info
    • About Journal
    • Aims and Scope
    • Editorial Board
    • Publication Ethics
    • Peer Review Process
  • Guide for Authors
  • Submit Manuscript
  • Contact Us
 
  • Login
  • Register
Home Articles List Article Information
  • Save Records
  • |
  • Printable Version
  • |
  • Recommend
  • |
  • How to cite Export to
    RIS EndNote BibTeX APA MLA Harvard Vancouver
  • |
  • Share Share
    CiteULike Mendeley Facebook Google LinkedIn Twitter
Journal of Medical Histology
arrow Articles in Press
arrow Current Issue
Journal Archive
Volume Volume 8 (2024)
Volume Volume 7 (2023)
Volume Volume 6 (2022)
Volume Volume 5 (2021)
Volume Volume 4 (2020)
Volume Volume 3 (2019)
Issue Issue 2
Issue Issue 1
Volume Volume 2 (2018)
Volume Volume 1 (2017)
Sorour, H., Abd-Elgalil, M. (2019). Mesenchymal Stem cells Ameliorate Diabetic Renocortical Changes In A Rat Model: Histological, Morphometrical And Biochemical Study. Journal of Medical Histology, 3(2), 132-161. doi: 10.21608/jmh.2020.40093.1080
Hekmat Sorour; Mona Abd-Elgalil. "Mesenchymal Stem cells Ameliorate Diabetic Renocortical Changes In A Rat Model: Histological, Morphometrical And Biochemical Study". Journal of Medical Histology, 3, 2, 2019, 132-161. doi: 10.21608/jmh.2020.40093.1080
Sorour, H., Abd-Elgalil, M. (2019). 'Mesenchymal Stem cells Ameliorate Diabetic Renocortical Changes In A Rat Model: Histological, Morphometrical And Biochemical Study', Journal of Medical Histology, 3(2), pp. 132-161. doi: 10.21608/jmh.2020.40093.1080
Sorour, H., Abd-Elgalil, M. Mesenchymal Stem cells Ameliorate Diabetic Renocortical Changes In A Rat Model: Histological, Morphometrical And Biochemical Study. Journal of Medical Histology, 2019; 3(2): 132-161. doi: 10.21608/jmh.2020.40093.1080

Mesenchymal Stem cells Ameliorate Diabetic Renocortical Changes In A Rat Model: Histological, Morphometrical And Biochemical Study

Article 2, Volume 3, Issue 2, December 2019, Page 132-161  XML PDF (22.96 MB)
Document Type: Original Article
DOI: 10.21608/jmh.2020.40093.1080
View on SCiNiTO View on SCiNiTO
Authors
Hekmat Sorour; Mona Abd-Elgalil*
Histology Department, Faculty of Medicine for Girls, Al-Azhar University, Cairo, Egypt
Abstract
Background: Diabetic nephropathy (DN) is the most leading complication of renal disease. Mesenchymal stem cells (MSCs)
therapy holds an excellent promise in the repair of injured tissues and organs. However, the precise effects of MSCs on renal
cellular injury remain unclear.
Objective: This work was designed to evaluate the possible reno-therapeutic role of MSCs in experimental streptozotocin
(STZ)-induced DN in adult female albino rat model.
Materials and Methods: Adult female albino rats were divided into three groups: Group I (control), Group II (diabetic group)
and Group III (diabetic/MSCs treated group) where 1X10^6 iron oxide-labeled MSCs was infused once in rat tail vein. Blood
glucose levels and biochemical parameters of the kidney function such as serum creatinine (Cr), blood urea nitrogen (BUN)
and uric acid were estimated. After 8 weeks, kidney specimens were processed for light and electron microscopic studies.
Morphometric measurements and statistical analyses were done.
Results: STZ injection caused destructive glomerular, proximal (PCT) and distal (DCT) convoluted tubular changes within the
renal tissue in the form of sloughed epithelium, vacuolated cytoplasm, pyknotic nuclei, congested blood vessels and mononuclear
inflammatory cells infiltration that was supported by a significant increase in plasma concentrations of Cr, BUN and uric acid
levels coupled to a significant elevation of Periodic-Acid-Schiff (PAS) reaction and increase in area percentage of collagen
fibers. The ultrastructural assessment confirmed these distortions. In contrast, MSCs significantly corrected hyperglycemia and
renal biochemical parameters with critical improvement in renal histopathological changes depicted previously.
Conclusion: MSC-based therapies may play a substantial therapeutic role in DN.
Keywords
Diabetic nephropathy; mesenchymal stem cells; Streptozotocin; diabetes mellitus
Statistics
Article View: 225
PDF Download: 566
Home | Glossary | News | Aims and Scope | Sitemap
Top Top

Journal Management System. Designed by NotionWave.